StockDocs
Project by Matthew Castle Please send feedback to matthewgcastle@gmail.com
CYAN

Cyanotech Corporation

CYAN OTC Medicinal Chemicals & Botanical Products EDGAR ↗
$0.53
+0.00 0.00%

Key statistics

from XBRL data in SEC filings
Market cap
$3.92M
Revenue (TTM)
$25.3M
Net income (TTM)
-$1.78M
EPS (TTM)
$-0.25
P/E ratio
Dividend yield
Free cash flow
-$1.62M
Cash
$649K
Total assets
$24.0M
Gross margin
32.0%
52-week range
$0.21 – $0.57

Recent SEC filings

40 most recent
Annual, quarterly & current reports
10-Q Quarter ended 2025-09-30 Nov 10, 2025 8-K Entered a material agreement; Took on a direct financial obligation Sep 2, 2025 8-K Director or officer change; Shareholder vote results; Other events Aug 22, 2025 10-Q Quarter ended 2025-06-30 Aug 6, 2025 10-K Fiscal year ended 2025-03-31 Jun 20, 2025 8-K Entered a material agreement; Took on a direct financial obligation; Director or officer change May 8, 2025 10-Q Quarter ended 2024-12-31 Feb 11, 2025 8-K Changed accountants Dec 16, 2024 10-Q Quarter ended 2024-09-30 Nov 12, 2024 8-K Director or officer change; Shareholder vote results; Other events Aug 23, 2024 8-K Entered a material agreement; Took on a direct financial obligation Aug 13, 2024 10-Q Quarter ended 2024-06-30 Aug 7, 2024 10-K Fiscal year ended 2024-03-31 Jun 26, 2024 8-K Delisting notice or listing-rule failure Feb 14, 2024 10-Q Quarter ended 2023-12-31 Feb 8, 2024 8-K Unregistered sale of equity Dec 19, 2023 10-Q Quarter ended 2023-09-30 Nov 8, 2023 8-K Shareholder vote results; Other events Aug 29, 2023 8-K Entered a material agreement; Took on a direct financial obligation Aug 17, 2023 8-K Delisting notice or listing-rule failure Aug 11, 2023 10-Q Quarter ended 2023-06-30 Aug 11, 2023 8-K Other events Jul 5, 2023 10-K Fiscal year ended 2023-03-31 Jun 27, 2023 8-K Other events Jun 16, 2023 8-K Delisting notice or listing-rule failure May 8, 2023 10-Q Quarter ended 2022-12-31 Feb 9, 2023 8-K Entered a material agreement; Took on a direct financial obligation Dec 19, 2022 10-Q Quarter ended 2022-09-30 Nov 9, 2022 8-K Shareholder vote results Aug 30, 2022 10-Q Quarter ended 2022-06-30 Aug 10, 2022 10-K Fiscal year ended 2022-03-31 Jun 22, 2022 8-K Entered a material agreement; Director or officer change Jun 22, 2022 10-Q Quarter ended 2021-12-31 Feb 10, 2022 10-Q Quarter ended 2021-09-30 Nov 10, 2021 8-K Director or officer change Nov 10, 2021 8-K Shareholder vote results Aug 31, 2021 10-Q Quarter ended 2021-06-30 Aug 11, 2021 10-K Fiscal year ended 2021-03-31 Jun 22, 2021 8-K Director or officer change May 25, 2021 8-K Entered a material agreement; Took on a direct financial obligation Apr 16, 2021